semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42629417
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
- 저자
- Ilaria Ammendolia, Cristina Mondello, Emanuela Esposito, Gioacchino Calapai, Mariaconcetta Currò, Paola Midiri
- 저널
- Naunyn-Schmiedeberg's archives of pharmacology
- 공개일
- 2026 Aug 22
- 연구 유형
- 기타
- DOI
- 10.1007/s00210-026-05813-9
문헌 요약
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) semaglutide, liraglutide, and dulaglutide are indicated for diabetes. Semaglutide and liraglutide were also approved for therapy of obesity or weight control. Apprehension has been expressed about the possible link between GLP-1 RAs and suicidality. Drug agencies established no causal relationship, but…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.